Aspire Biopharma: Funding, Investors & Team (Sep 2026)
Aspire Biopharma is a biotechnology company specializing in nanotechnology-based drug formulation and the development of medicinal products. The company focuses on enhancing drug delivery systems to improve bioavailability and therapeutic effectiveness. Its research and development efforts aim to advance pharmaceutical solutions across various therapeutic areas.
Aspire Biopharma has raised $22.5M across 1 funding round on record, the most recent an undisclosed round of $22.5M announced in Apr 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Aspire Biopharma Company Profile and Key Stats
Latest funding round on record: Apr 2026.
Aspire Biopharma Funding Rounds
Aspire Biopharma Founders and Leadership Team
No contact details are on record for this team yet.
Aspire Biopharma Funding Compared to Other Biotechnology Startups
Aspire Biopharma's latest round of $22.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Aspire Biopharma in Biotechnology and San Juan
Companies Similar to Aspire Biopharma
Island (ASX: ILA) is a drug repurposing company, focused on the rapid development of antiviral therapeutics…
Connecta Therapeutics is a biotechnology company that develops new treatments for unresolved medical needs of…
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
iPremom is a healthcare technology company that develops molecular diagnostic solutions for the early…
Wren Bioscience is developed to give rapid, reliable bacterial identification anywhere milk safety is…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
Aspire Biopharma Funding FAQs
What does Aspire Biopharma do?
Aspire Biopharma is a biotechnology company specializing in nanotechnology-based drug formulation and the development of medicinal products. The company focuses on enhancing drug delivery systems to improve bioavailability and therapeutic effectiveness. Its research and development efforts aim to advance pharmaceutical solutions across various therapeutic areas.
How much funding has Aspire Biopharma raised?
Aspire Biopharma has raised $22.5M across 1 round on record. The most recent is an undisclosed round of $22.5M announced in Apr 2026.
When did Aspire Biopharma last raise funding?
Aspire Biopharma's most recent funding round on record is an undisclosed round of $22.5M, announced in Apr 2026.
Who founded Aspire Biopharma?
FundedIQ lists Lance B (Founder) at Aspire Biopharma.
Where is Aspire Biopharma headquartered?
Aspire Biopharma is based in San Juan, NA - Puerto Rico, Puerto Rico.
How many employees does Aspire Biopharma have?
Aspire Biopharma is in the 11-50 employee band.
How does Aspire Biopharma's funding compare to other Biotechnology startups?
Aspire Biopharma's latest round of $22.5M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Aspire Biopharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Aspire Biopharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.